Announcements
-
2022 / 12 / 13VOLUNTARY ANNOUNCEMENT - Enrollment in the China Randomized Controlled Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Completed
-
2022 / 12 / 05MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2022
-
2022 / 11 / 03MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2022
-
2022 / 10 / 20VOLUNTARY ANNOUNCEMENT - Admission of Innovative Medical Devices in respect of Aortic Arch Stent Graft System (Fenestration) into Special Examination and Approval Procedure
-
2022 / 10 / 05MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2022
-
2022 / 09 / 05FDA Approved Investigator-initiated Pre-market Clinical Trial of LAmbre? Plus LAA Closure System Obtained Medical Insurance Coverage in the US
-
2022 / 09 / 02MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2022
-
2022 / 08 / 30INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2022
-
2022 / 08 / 12NOTICE OF BOARD MEETING
-
2022 / 08 / 03MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2022
